MeadowBrook Investment Advisors LLC Has $284,000 Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

MeadowBrook Investment Advisors LLC decreased its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 28.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,820 shares of the company’s stock after selling 3,500 shares during the period. MeadowBrook Investment Advisors LLC’s holdings in Surgery Partners were worth $284,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. KBC Group NV increased its position in shares of Surgery Partners by 31.8% in the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after purchasing an additional 576 shares during the period. DekaBank Deutsche Girozentrale increased its position in shares of Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after purchasing an additional 1,375 shares during the period. Quarry LP increased its position in shares of Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after purchasing an additional 1,760 shares during the period. EntryPoint Capital LLC increased its position in shares of Surgery Partners by 257.1% in the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after purchasing an additional 4,607 shares during the period. Finally, Creative Planning bought a new position in shares of Surgery Partners in the third quarter worth $258,000.

Analyst Ratings Changes

SGRY has been the topic of a number of recent analyst reports. Benchmark reiterated a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research report on Monday, August 26th. UBS Group initiated coverage on Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price on the stock. Citigroup decreased their target price on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a research report on Friday, October 4th. Finally, StockNews.com cut Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $40.00.

Surgery Partners Trading Down 2.8 %

Shares of Surgery Partners stock traded down $0.72 during midday trading on Thursday, reaching $24.78. The company had a trading volume of 353,109 shares, compared to its average volume of 939,945. The stock has a fifty day moving average price of $30.88 and a 200 day moving average price of $28.47. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.83 and a quick ratio of 1.69. The firm has a market cap of $3.15 billion, a PE ratio of -53.46, a P/E/G ratio of 2.34 and a beta of 2.76. Surgery Partners, Inc. has a fifty-two week low of $22.25 and a fifty-two week high of $36.92.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.